Advertisement
Advertisement
VALN
Valneva SE - ADR
9.45
USDSponsored
+0.12
+1.23%
Feb 06, 15:58 UTC -5
Closed
After-Market
9.45
0.00
0.00%
VALN Earnings Reports
Positive Surprise Ratio
VALN beat 12 of 27 last estimates.
44%
Next Report
Date of Next Report
Feb 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
$38.90M
/-$0.21
Implied change from Q3 25 (Revenue/ EPS)
+32.14%
/-19.23%
Implied change from Q4 24 (Revenue/ EPS)
-26.52%
/-16.00%
Valneva SE - ADR earnings per share and revenue
On Nov 20, 2025, VALN reported earnings of -0.26 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -90.62% surprise. Revenue reached 29.44 million, compared to an expected 40.25 million, with a -26.86% difference. The market reacted with a -1.95% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 38.90 million USD, implying an decrease of -19.23% EPS, and increase of 32.14% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
FAQ
What were Valneva SE - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Valneva SE - ADR reported EPS of -$0.26, missing estimates by -90.62%, and revenue of $29.44M, -26.86% below expectations.
How did the market react to Valneva SE - ADR's Q3 2025 earnings?
The stock price moved down -1.95%, changed from $8.70 before the earnings release to $8.53 the day after.
When is Valneva SE - ADR expected to report next?
The next earning report is scheduled for Feb 19, 2026.
What are the forecasts for Valneva SE - ADR's next earnings report?
Based on 3
analysts, Valneva SE - ADR is expected to report EPS of -$0.21 and revenue of $38.90M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement